-+ 0.00%
-+ 0.00%
-+ 0.00%

WINDTREE THERAPEUTICS ANNOUNCES ISTAROXIME CARDIOGENIC SHOCK SCAI STAGE C PHASE 2 STUDY PLANNED INTERIM ANALYSIS RESULTS TARGETED FOR JULY 2025

Reuters·05/22/2025 12:17:18

Please log in to view news